biguanides has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Luo, C | 1 |
| Miao, L | 1 |
| Zhao, Y | 1 |
| Musetti, S | 1 |
| Wang, Y | 1 |
| Shi, K | 1 |
| Huang, L | 1 |
1 other study available for biguanides and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
A novel cationic lipid with intrinsic antitumor activity to facilitate gene therapy of TRAIL DNA.
Topics: Animals; Antineoplastic Agents; Biguanides; Carcinoma, Non-Small-Cell Lung; Cell Line; Cell Line, Tu | 2016 |